Clinical Trials Logo

Clinical Trial Summary

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05795699
Study type Interventional
Source Kowa Research Institute, Inc.
Contact Director, Clinical Operations
Phone 919-433-1600
Email Clinical@KowaUS.com
Status Recruiting
Phase Phase 3
Start date March 30, 2023
Completion date January 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04440280 - Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy Phase 2
Active, not recruiting NCT05376176 - A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) Phase 2
Recruiting NCT05826353 - A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) Phase 3
Recruiting NCT04387331 - The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK
Active, not recruiting NCT04894110 - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema Phase 1
Completed NCT04520321 - A Phase 1/ Phase 2 Study of TTHX1114(NM141) Phase 1/Phase 2
Withdrawn NCT05052554 - Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3 Phase 1
Completed NCT03974230 - Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France.